rs876661161
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PM4
The NM_000179.3(MSH6):c.172_177dupAGGCCC(p.Arg58_Pro59dup) variant causes a conservative inframe insertion change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. L60L) has been classified as Likely benign.
Frequency
Consequence
NM_000179.3 conservative_inframe_insertion
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Uncertain:2
The c.172_177dupAGGCCC variant (also known as p.R58_P59dup), located in coding exon 1 of the MSH6 gene, results from an in-frame duplication of AGGCCC at nucleotide positions 172 to 177. This results in the duplication of 2 extra residues (RP) between codons 58 and 59. In a study of 63 cases of non-medullary thyroid cancer, this duplication (designated G56GPR) was identified in one proband with sporadic papillary thyroid cancer who also carried the MSH6 variant p.A53D. Both alterations were deemed likely benign, based on in silico predictions (Yu Y et al. Sci Rep, 2015 Nov;5:16129). The duplicated nucleotide region is not well conserved in available vertebrate species. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
This variant causes an in-frame duplication of two amino acids in the MSH6 protein. To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with MSH6-related disorders in the literature. This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
Lynch syndrome Uncertain:1
This variant causes an in-frame duplication of two amino acids in the MSH6 protein. To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with MSH6-related disorders in the literature. This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
not provided Uncertain:1
Not observed at significant frequency in large population cohorts (gnomAD); In-frame duplication of 2 amino acid(s) in a non-repeat region; Also known as c.177_178insAGGCCC; This variant is associated with the following publications: (PMID: 26530882, 35171259, 35449176) -
Hereditary nonpolyposis colorectal neoplasms Uncertain:1
This variant, c.172_177dup, results in the insertion of 2 amino acid(s) of the MSH6 protein (p.Arg58_Pro59dup), but otherwise preserves the integrity of the reading frame. This variant is not present in population databases (gnomAD no frequency). This variant has been observed in individual(s) with pancreatic cancer (PMID: 35171259). This variant is also known as c.177_178insAGGCCC. ClinVar contains an entry for this variant (Variation ID: 234685). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Endometrial carcinoma Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at